gunnar: great post...much better. see my thoughts below in caps...
-- Biocurex is a tiny, almost nonexistent company making an extraordinary claim about its technology. If everything they claim is true, this is a great find and patient investors will be greatly rewarded.
YUP
-- There is a huge disconnect between what the company claims and its apparent lack of success convincing the scientific and investment worlds.
I GUESS CONVINCING THE SECOND LARGEST DIAGNOSTICS COMPANY IN THE WORLD DOESN'T COUNT. ??? ARE YOU OUT OF YOUR F'ING MIND?
-- Abbott must see some potential, but long after obtaining the technology and beginning work on it Abbott still has not committed to the technology, and no other pharmas have either.
REGARDING ABBOTT, YOU MAY BE UNDERESTIMATING THE TIMELINE OF THE R&D PROCESS. IT'S BEEN A YEAR AND A HALF, WHICH MAY SEEM LIKE AN ETERNITY FOR THE IMPATIENT INVESTOR. BUT IN THE SCIENCE WORLD, THAT IS BUT A BLIP. THEY ARE TAKING AN RIA ASSAY AND TURNING IT INTO A COLORIMETRIC ASSAY THAT SUITS THE ARCHITECT SPECS. DO YOU HAVE ANY IDEA WHAT THIS INVOLVES? I SURE AS HELL DON'T. I THINK IT'S A LITTLE PREMATEUR TO ASSUME THAT ABBOTT IS NOT INTERESTED SIMPLY BECAUSE A YEAR AND A CHANGE HAS PASSED SINCE THEY INKED THE DEAL!
REGARDING "OTHER PHARMAS" -- KEEP IN MIND THAT IT TOOK BOCX A HELL OF A LOT OF TIME TO INK THE DEAL WITH ABBOTT. IN MY OPINION, THEY DON'T NEED ANYONE ELSE BUT ABBOTT. I COULD CARE LESS ABOUT "OTHER PHARMAS" -- WE HAVE THE #2 IN THE INDUSTRY ON OUR SIDE.
News 
Market Data 
Discover 
